SCHEMBL26292178

SCHEMBL26292178

CCc1ncccc1-c1cc2ccc(OCO)cc2o1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 5/20 0.42
▸ NPC1 O15118 4/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ KDM4E B2RXH2 3/20 0.42
▸ GAA P10253 3/20 0.42
▸ HPGD P15428 3/20 0.42
▸ GLA P06280 2/20 0.42
▸ MAPT P10636 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ PTPN1 P18031 1/20 0.39
▸ PDE4D Q08499 2/20 0.38
▸ S1PR1 P21453 1/20 0.37
▸ S1PR3 Q99500 1/20 0.37
▸ CA12 O43570 4/20 0.36
▸ CA1 P00915 4/20 0.36
▸ CA9 Q16790 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23395657 0.88 PTPN1 (0.49) RAB9ANPC1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL23395599 0.83 PDE4D (0.54) PTPN1PDE4DAPP
SCHEMBL23893560 0.82 KDM4E (0.36) RAB9ANPC1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL23395722 0.82 ALDH1A1 (0.36) RAB9ANPC1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL26291695 0.82 ALDH1A1 (0.40) RAB9ANPC1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL26291692 0.82 RAB9A (0.38) RAB9ANPC1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL26292124 0.81 RAB9A (0.46) RAB9ANPC1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL23395686 0.80 APP (0.35) RAB9ANPC1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL23395715 0.76 ALDH1A1 (0.33) RAB9ANPC1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL25901309 0.75 RAB9A (0.33) RAB9ANPC1ALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11753387-B2 Compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-09-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11753387-B2 Compounds for optically active devices PDE6C, PDE6A, PDE6D RAB9A 1119/4885NPC1 2727/4885ALDH1A1 388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback